Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,558
Closed -$135K 4339
2017
Q2
$161K Buy
+2,558
New +$149K ﹤0.01% 3534
2017
Q1
Sell
-12,906
Closed -$550K 4246
2016
Q4
$550K Buy
+12,906
New +$549K ﹤0.01% 2421
2013
Q4
Sell
-52,400
Closed -$844K 4846
2013
Q3
$451K Buy
+52,400
New +$777K ﹤0.01% 2895

Other funds holding AMED

PEAK6 Group's AMED Position: Q3 2017 in Review

PEAK6 Group sold out of Amedisys (AMED) in Q3 2017, closing a stake of 2,558 shares — an estimated $135K sold.

PEAK6 Group first reported a position in AMED in Q3 2013 and held it in 3 quarters. The position peaked at $550K in Q4 2016. 163 funds tracked by Wall St. Rank hold AMED as of Q3 2017.

  • PEAK6 Group reported no remaining Amedisys position as of Q3 2017 after selling out during the quarter.
  • PEAK6 Group sold 2,558 Amedisys shares in Q3 2017, an estimated $135K.
  • PEAK6 Group first reported a position in Amedisys in Q3 2013 and held it in 3 quarters.
  • PEAK6 Group's Amedisys position peaked at $550K in Q4 2016.
  • 163 funds tracked by Wall St. Rank held Amedisys as of Q3 2017.

Based on PEAK6 Group's 13F filing for Q3 2017, filed 14 Nov 2017.